Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BDX stock price vs GWW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at GWW's multiple
Needs GWW P/E.
Implied fair value · at BDX's multiple
Needs BDX P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BECTON, DICKINSON AND COMPANY · implied price per share
Bear
$42.31
Base
$61.15
Bull
$85.69
W.W. Grainger, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Johnson & Johnson
BDX vs JNJ
Medtronic plc
BDX vs MDT
DANAHER CORP /DE/
BDX vs DHR
STRYKER CORP
BDX vs SYK
FASTENAL CO
BDX vs FAST
MSC INDUSTRIAL DIRECT CO INC
BDX vs MSM
APPLIED INDUSTRIAL TECHNOLOGIES INC
BDX vs AIT
GENUINE PARTS CO
BDX vs GPC
AGILENT TECHNOLOGIES, INC.
BDX vs A
3M CO
BDX vs MMM
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe BDX can sustain 8.2% revenue growth while improving margins and keeping leverage near current levels, then the stock looks worth owning because it trades below the P/E-implied price and below GWW on most valuation multiples.
BDX trades at $170.21 versus a P/E-implied price of $225.44, suggesting 32.4% upside on the selected multiple. However, BDX also sits below GWW-implied range and closer to the low end of its historical band, so the gap looks meaningful but not unambiguously cheap given quality differences versus GWW.
Supporting Metrics
